| Title {1} | Bronchiectasis - Exercise as Therapy (BREATH): rationale and study protocol for a multi-center randomized controlled trial |
| Trial registration {2a and 2b} | Australian and New Zealand Clinical Trials Register (ANZCTR) number ACTRN12619001008112. The ANZCTR is recognized by the World Health Organization International Clinical Trials Registry Platform as a Primary Registry. |
| Protocol version {3} | 10 August 2021, Version 4 |
| Funding {4} | National Health and Medical Research Council Grant |
| Names, affiliations, and roles of protocol contributors {5a} | 1Queensland University of Technology, Brisbane, QLD, Australia. 2Queensland Children’s Hospital, Brisbane, QLD, Australia. 3Gold Coast University Hospital, Gold Coast, QLD, Australia. 4The University of Queensland, Brisbane, QLD, Australia. 5Menzies School of Health Research, Darwin, NT, Australia. 6George Institute for Global Health, Sydney, NSW, Australia. 7Griffith University, QLD, Australia. |
| Name and contact information for the trial sponsor {5b} |
Professor Stewart Trost Queensland University of Technology Centre for Children’s Health Research (CCHR) Level 4, 62 Graham Street South Brisbane QLD 4101 s.trost@qut.edu.au + 61 7 3069 7301 |
| Role of sponsor {5c} | The study sponsor is responsible for the study design; collection, management, analysis, and interpretation of the data; writing of the report; and decision to submit the report for publication. The study sponsor will be responsible for the overall coordination of the trial and will work closely with the clinical chief/associate investigators to monitor the project staff and trial conduct at each site. |